Recombinant multi-species BRD7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BRD7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein which is a member of the bromodomain-containing protein family. The product of this gene has been identified as a component of one form of the SWI/SNF chromatin remodeling complex, and as a protein which interacts with p53 and is required for p53-dependent oncogene-induced senescence which prevents tumor growth. Pseudogenes have been described on chromosomes 2, 3, 6, 13 and 14. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]
The Alternative Names of target: 75 kDa bromodomain protein,BP75,BRD7,Brd7,Bromodomain-containing protein 7,CELTIX1,NAG4,Protein CELTIX-1,Ptpn13ip,SMARCI1

Target products collectionGo to BRD7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T23984-Ag-1/ GM-Tg-hg-T23984-Ag-2 Human BRD7 protein Human
GM-Tg-rg-T23984-Ag-1/ GM-Tg-rg-T23984-Ag-2 Rat BRD7 protein Rat
GM-Tg-mg-T23984-Ag-1/ GM-Tg-mg-T23984-Ag-2 Mouse BRD7 protein Mouse
GM-Tg-cynog-T23984-Ag-1/ GM-Tg-cynog-T23984-Ag-2 Cynomolgus/Rhesus macaque BRD7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T23984-Ag-1/ GM-Tg-felg-T23984-Ag-2 Feline BRD7 protein Feline
GM-Tg-cang-T23984-Ag-1/ GM-Tg-cang-T23984-Ag-2 Canine BRD7 protein Canine
GM-Tg-bovg-T23984-Ag-1/ GM-Tg-bovg-T23984-Ag-2 Bovine BRD7 protein Bovine
GM-Tg-equg-T23984-Ag-1/ GM-Tg-equg-T23984-Ag-2 Equine BRD7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T23984-Ag-1/ GM-Tg-hg-T23984-Ag-2; GM-Tg-rg-T23984-Ag-1/ GM-Tg-rg-T23984-Ag-2;
GM-Tg-mg-T23984-Ag-1/ GM-Tg-mg-T23984-Ag-2; GM-Tg-cynog-T23984-Ag-1/ GM-Tg-cynog-T23984-Ag-2;
GM-Tg-felg-T23984-Ag-1/ GM-Tg-felg-T23984-Ag-2; GM-Tg-cang-T23984-Ag-1/ GM-Tg-cang-T23984-Ag-2;
GM-Tg-bovg-T23984-Ag-1/ GM-Tg-bovg-T23984-Ag-2; GM-Tg-equg-T23984-Ag-1/ GM-Tg-equg-T23984-Ag-2
Products Name BRD7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name BRD7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BRD7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.